Objective: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.
Design: Qualitative systematic review.
Data Sources: Electronic literature searches of websites, bibliographic databases and discussion forums, including PubMed LitCovid, Proquest COVID, EPPI Centre living systematic map of evidence, medRxiv, bioRxiv, Medline, Psychinfo and Web of Science Core Collection were conducted to identify qualitative literature published in English up to 13 January 2021.
Objective: To identify the number of drug-disease and drug-drug interactions for exemplar index conditions within National Institute of Health and Care Excellence (NICE) clinical guidelines.
Design: Systematic identification, quantification, and classification of potentially serious drug-disease and drug-drug interactions for drugs recommended by NICE clinical guidelines for type 2 diabetes, heart failure, and depression in relation to 11 other common conditions and drugs recommended by NICE guidelines for those conditions.
Setting: NICE clinical guidelines for type 2 diabetes, heart failure, and depression
Main Outcome Measures: Potentially serious drug-disease and drug-drug interactions.